NUDT13

Across TCGA pan-cancer cohorts, NUDT13 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated NUDT13 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher NUDT13 RNA is associated with better overall survival. In most high-consensus cancer types, elevated NUDT13 expression acts as an unfavorable survival marker, although some lineages such as MESO and READ show a favorable association.

MESO, READ, and UVM are the cancer types where NUDT13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Quartile	II,III,IV	0.764	0.399	<.001	49	view →
READ	OS	Median	II,III,IV	1.000	0.290	<.001	40	view →
UVM	DFS	Tertile	III,IV	0.282	0.860	.003	39	view →
SKCM	OS	Tertile	III,IV	0.864	0.680	.001	27	view →
KIRP	OS	Quartile	II,III,IV	0.860	0.499	.001	24	view →
ACC	OS	Quartile	All	0.614	0.939	.004	17	view →
PRAD	OS	Median	All	0.800	0.972	.004	16	view →
HNSC	OS	Median	All	0.618	0.791	.004	14	view →
STAD	DFS	Median	IV	0.210	0.649	.018	12	view →
THCA	OS	Tertile	All	0.959	0.992	.019	10	view →
SARC	DFS	Tertile	All	0.724	0.517	.016	8	view →
KIRC	DFS	Quartile	IV	0.718	0.356	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

NUDT13–MESO (OS)

Open the MESO breakdown →